Last update 07 Mar 2025

CHA Vaccine Research Institute Co., Ltd.

Public Company|
2000|
South Korea
|
10-50
| KRX: 261780|
www.chavaccine.com

Overview

Tags

Infectious Diseases
Digestive System Disorders
Neoplasms
Prophylactic vaccine
Therapeutic vaccine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Infectious Diseases5
Neoplasms1
Top 5 Drug TypeCount
Prophylactic vaccine4
Therapeutic vaccine2

Related

6
Drugs associated with CHA Vaccine Research Institute Co., Ltd.
CVI-HBV-002
Target-
Mechanism
Immunostimulants
Active Org.
CHA Vaccine Research Institute Co., Ltd.
Originator Org.
CHA Vaccine Research Institute Co., Ltd.
Active Indication
Hepatitis B, Chronic
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
CVI-HBV-001
Target-
Mechanism
Immunostimulants
Active Org.
CHA Vaccine Research Institute Co., Ltd.
Originator Org.
CHA Vaccine Research Institute Co., Ltd.
Active Indication
Hepatitis B
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
CVI-VZV-001
Target-
Mechanism-
Active Org.
CHA Vaccine Research Institute Co., Ltd.
Originator Org.
CHA Vaccine Research Institute Co., Ltd.
Active Indication
Herpes Zoster [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
5
Clinical Trials associated with CHA Vaccine Research Institute Co., Ltd.
NCT06137755
/ RecruitingPhase 1
A Multicenter, Active-controlled, Open-label Phase I Study to Assess Safety and Tolerability and to Explore Immunogenicity of CVI-VZV-001 Vaccine in Healthy Adults Aged 50 to 64 Years
NCT06147895
/ CompletedPhase 1
A Randomized, Open-labelled, Parallel, Phase 1 Clinical Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Hepatitis B Vaccine CVI-HBV-002 in Adults
NCT04289987
/ CompletedPhase 2
A Randomized, Double-blinded, Placebo-controlled, Parallel, Multicenter, Phase 2b Study to Evaluate the Efficacy and Safety of CVI-HBV-002 in Patients With Chronic Hepatitis B Taking Tenofovir
100 Clinical Results associated with CHA Vaccine Research Institute Co., Ltd.
Login to view more data
0 Patents (Medical) associated with CHA Vaccine Research Institute Co., Ltd.
Login to view more data
100 Deals associated with CHA Vaccine Research Institute Co., Ltd.
Login to view more data
100 Translational Medicine associated with CHA Vaccine Research Institute Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 09 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
3
1
Phase 1
Phase 2
2
1
Other
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free